Your browser doesn't support javascript.
loading
A comparative study of structural variant calling in WGS from Alzheimer's disease families.
Malamon, John S; Farrell, John J; Xia, Li Charlie; Dombroski, Beth A; Das, Rueben G; Way, Jessica; Kuzma, Amanda B; Valladares, Otto; Leung, Yuk Yee; Scanlon, Allison J; Lopez, Irving Antonio Barrera; Brehony, Jack; Worley, Kim C; Zhang, Nancy R; Wang, Li-San; Farrer, Lindsay A; Schellenberg, Gerard D; Lee, Wan-Ping; Vardarajan, Badri N.
Afiliação
  • Malamon JS; Department of Pathology and Laboratory Medicine, Penn Neurodegeneration Genomics Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Farrell JJ; Biomedical Genetics Section, Department of Medicine, Boston University School of Medicine, Boston University, Boston, MA, USA.
  • Xia LC; https://ror.org/03mtd9a03 Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Dombroski BA; Department of Statistics, The Wharton School, University of Pennsylvania, Philadelphia, PA, USA.
  • Das RG; Department of Pathology and Laboratory Medicine, Penn Neurodegeneration Genomics Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Way J; Department of Pathology and Laboratory Medicine, Penn Neurodegeneration Genomics Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Kuzma AB; Broad Institute, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Valladares O; Department of Pathology and Laboratory Medicine, Penn Neurodegeneration Genomics Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Leung YY; Department of Pathology and Laboratory Medicine, Penn Neurodegeneration Genomics Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Scanlon AJ; Department of Pathology and Laboratory Medicine, Penn Neurodegeneration Genomics Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Lopez IAB; Department of Pathology and Laboratory Medicine, Penn Neurodegeneration Genomics Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Brehony J; Department of Pathology and Laboratory Medicine, Penn Neurodegeneration Genomics Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Worley KC; Department of Pathology and Laboratory Medicine, Penn Neurodegeneration Genomics Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Zhang NR; https://ror.org/02pttbw34 Human Genome Sequencing Center, and Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
  • Wang LS; Department of Statistics, The Wharton School, University of Pennsylvania, Philadelphia, PA, USA.
  • Farrer LA; Department of Pathology and Laboratory Medicine, Penn Neurodegeneration Genomics Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Schellenberg GD; Biomedical Genetics Section, Department of Medicine, Boston University School of Medicine, Boston University, Boston, MA, USA.
  • Lee WP; Departments of Neurology and Ophthalmology, Boston University School of Medicine, Boston University, Boston, MA, USA.
  • Vardarajan BN; Departments of Epidemiology and Biostatistics, Boston University School of Public Health, Boston, MA, USA.
Life Sci Alliance ; 7(5)2024 May.
Article em En | MEDLINE | ID: mdl-38418088
ABSTRACT
Detecting structural variants (SVs) in whole-genome sequencing poses significant challenges. We present a protocol for variant calling, merging, genotyping, sensitivity analysis, and laboratory validation for generating a high-quality SV call set in whole-genome sequencing from the Alzheimer's Disease Sequencing Project comprising 578 individuals from 111 families. Employing two complementary pipelines, Scalpel and Parliament, for SV/indel calling, we assessed sensitivity through sample replicates (N = 9) with in silico variant spike-ins. We developed a novel metric, D-score, to evaluate caller specificity for deletions. The accuracy of deletions was evaluated by Sanger sequencing. We generated a high-quality call set of 152,301 deletions of diverse sizes. Sanger sequencing validated 114 of 146 detected deletions (78.1%). Scalpel excelled in accuracy for deletions ≤100 bp, whereas Parliament was optimal for deletions >900 bp. Overall, 83.0% and 72.5% of calls by Scalpel and Parliament were validated, respectively, including all 11 deletions called by both Parliament and Scalpel between 101 and 900 bp. Our flexible protocol successfully generated a high-quality deletion call set and a truth set of Sanger sequencing-validated deletions with precise breakpoints spanning 1-17,000 bp.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Idioma: En Ano de publicação: 2024 Tipo de documento: Article